Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Quintessence Biosciences, Inc.

Quintessence Biosciences, Inc., funded in 2003, is an early stage biopharmaceutical company focused on development of human therapeutics. The Company's EVade™ technology provides the means to reengineer mammalian proteins to be cytotoxic to cancer cells.
The company is based on based on technologies discovered by Drs. Ronald Raines and Laura Kiessling at the University of Wisconsin-Madison. These technologies are licensed through the Wisconsin Alumni Research Foundation (WARF). Presently, Quintessence Biosciences, Inc. has exclusive rights to five patented technologies derived from the Raines and Kiessling laboratories and will serve as a conduit for their future discoveries.


Contact Details:
505 South Rosa Road
Madison
Wisconsin
53719
United States of America
Tel:608.441.2950
Fax:608.441.2952
Email:info@quintbio.com
WWW:

www.quintbio.com/




Loading...

Press Releases on Quintessence Biosciences, Inc.:

BioPortfolio Logo
/C O R R E C T I O N -- International Business Forum/ 30th September, 2009 International Business Forum
In the news release, Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum, issued 29-Sep-2009 by International Business Forum over PR Newswire, we are advised by the
Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 29th September, 2009 International Business Forum
MASSAPEQUA, N.Y., Sept. 29 /PRNewswire/ -- International Business Forum, Inc. and the Mid-America Healthcare Investors Network (MHIN) will jointly present the 7th Annual MidAmerica Healthcare Venture
Valuing In-Licensed Therapeutics and Technologies - Biotech and 1st January, 1970 Bioportfolio
    Don't miss out on this must-attend event! 
Cambridge Healthtech Institute - Licensing and Partner Congress 1st January, 1970 Bioportfolio
      Pharmaceutical Strategy Series presents....Licensing &

BioNews Results for Quintessence Biosciences, Inc.:

Pressure BioSciences, Inc. to Discuss Third Quarter 2009 Financial Results and Provide Business Update
World Market Media:  Nov 14 2009 5:12AM Matching: biosciences inc
Pressure BioSciences, Inc. to Discuss Third Quarter 2009 Financial Results and Provide Business Update
TradingMarkets:  Nov 13 2009 8:35PM Matching: biosciences inc
Pressure BioSciences, Inc. to Discuss Third Quarter 2009 Financial Results and Provide Business Update
StockHouse USA:  Nov 13 2009 8:31PM Matching: biosciences inc
Pressure BioSciences, Inc. to Discuss Third Quarter 2009 Financial Results and Provide
Reuters:  Nov 13 2009 8:45PM Matching: biosciences inc
Pressure BioSciences, Inc. to Discuss Third Quarter 2009 Financial Results and Provide Business Update
DMN Newswire:  Nov 13 2009 8:53PM Matching: biosciences inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Quintessence Biosciences, Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 309 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: Laura Kiessling 2009 | quintbio | .

Search for more companies in Madison

Search for more companies in Wisconsin



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Quintessence Biosciences, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.